114 related articles for article (PubMed ID: 2754758)
1. Effect of carbon monoxide on the cytochrome P-450-mediated activation of 4-ipomeanol by the isolated perfused rabbit lung.
Trela BA; Carlson GP; Turek J; Rebar A; Mathews JM
J Toxicol Environ Health; 1989; 27(3):341-50. PubMed ID: 2754758
[TBL] [Abstract][Full Text] [Related]
2. Effect of carbon monoxide on the cytochrome P-450-mediated metabolism of aniline and p-nitroanisole in the isolated perfused rabbit lung.
Trela BA; Carlson GP; Mayer PR
J Toxicol Environ Health; 1989; 27(3):331-40. PubMed ID: 2754757
[TBL] [Abstract][Full Text] [Related]
3. In vitro metabolic activation of the pulmonary toxin, 4-ipomeanol, in nonciliated bronchiolar epithelial (Clara) and alveolar type II cells isolated from rabbit lung.
Devereux TR; Jones KG; Bend JR; Fouts JR; Statham CN; Boyd MR
J Pharmacol Exp Ther; 1982 Jan; 220(1):223-7. PubMed ID: 7053419
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
Wolf CR; Statham CN; McMenamin MG; Bend JR; Boyd MR; Philpot RM
Mol Pharmacol; 1982 Nov; 22(3):738-44. PubMed ID: 7155130
[TBL] [Abstract][Full Text] [Related]
5. Metabolic activation and cytotoxicity of 4-ipomeanol in human non-small cell lung cancer lines.
Falzon M; McMahon JB; Schuller HM; Boyd MR
Cancer Res; 1986 Jul; 46(7):3484-9. PubMed ID: 3011249
[TBL] [Abstract][Full Text] [Related]
6. In vitro studies on the metabolic activation of the pulmonary toxin, 4-ipomeanol, by rat lung and liver microsomes.
Boyd MR; Burka LT; Wilson BJ; Sasame HA
J Pharmacol Exp Ther; 1978 Dec; 207(3):677-86. PubMed ID: 32381
[TBL] [Abstract][Full Text] [Related]
7. Relationship between alveolar PO2 and the rate of p-nitroanisole O-demethylation by the cytochrome P-450 pathway in isolated rabbit lungs.
Fisher AB; Itakura N; Dodia C; Thurman RG
J Clin Invest; 1979 Sep; 64(3):770-4. PubMed ID: 468992
[TBL] [Abstract][Full Text] [Related]
8. Covalent binding of metabolites of 4-ipomeanol to rabbit pulmonary and hepatic microsomal proteins and to the enzymes of the pulmonary cytochrome P-450-dependent monooxygenase system.
Slaughter SR; Statham CN; Philpot RM; Boyd MR
J Pharmacol Exp Ther; 1983 Jan; 224(1):252-7. PubMed ID: 6848746
[TBL] [Abstract][Full Text] [Related]
9. CYP4B1 activates 4-ipomeanol in rat lung.
Verschoyle RD; Philpot RM; Wolf CR; Dinsdale D
Toxicol Appl Pharmacol; 1993 Dec; 123(2):193-8. PubMed ID: 8248926
[TBL] [Abstract][Full Text] [Related]
10. In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol.
Boyd MR; Burka LT
J Pharmacol Exp Ther; 1978 Dec; 207(3):687-97. PubMed ID: 731424
[TBL] [Abstract][Full Text] [Related]
11. Elevated susceptibility to 4-ipomeanol cytotoxicity in immature Clara cells of neonatal rabbits.
Plopper CG; Weir AJ; Nishio SJ; Chang A; Voit M; Philpot RM; Buckpitt AR
J Pharmacol Exp Ther; 1994 May; 269(2):867-80. PubMed ID: 8182556
[TBL] [Abstract][Full Text] [Related]
12. The pulmonary clara cell as a target for toxic chemicals requiring metabolic activation; studies with carbon tetrachloride.
Boyd MR; Statham CN; Longo NS
J Pharmacol Exp Ther; 1980 Jan; 212(1):109-14. PubMed ID: 7351618
[TBL] [Abstract][Full Text] [Related]
13. Renal toxicity due to reactive metabolites formed in situ in the kidney: investigations with 4-ipomeanol in the mouse.
Boyd MR; Dutcher JS
J Pharmacol Exp Ther; 1981 Mar; 216(3):640-6. PubMed ID: 7205642
[TBL] [Abstract][Full Text] [Related]
14. Protective role of endogenous pulmonary glutathione and other sulfhydryl compounds against lung damage by alkylating agents. Investigations with 4-ipomeanol in the rat.
Boyd MR; Stiko A; Statham CN; Jones RB
Biochem Pharmacol; 1982 Apr; 31(8):1579-83. PubMed ID: 7092947
[TBL] [Abstract][Full Text] [Related]
15. The effect of carbon monoxide on aminopyrine metabolism in the isolated perfused rabbit lung.
Trela BA; Carlson GP; Mayer PR
Toxicol Appl Pharmacol; 1988 Dec; 96(3):442-50. PubMed ID: 3206526
[TBL] [Abstract][Full Text] [Related]
16. Metabolic basis for the pulmonary Clara cell as a target for pulmonary carcinogenesis.
Boyd MR; Reznik-Schüller HM
Toxicol Pathol; 1984; 12(1):56-61. PubMed ID: 6387866
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation of 4-ipomeanol by complementary DNA-expressed human cytochromes P-450: evidence for species-specific metabolism.
Czerwinski M; McLemore TL; Philpot RM; Nhamburo PT; Korzekwa K; Gelboin HV; Gonzalez FJ
Cancer Res; 1991 Sep; 51(17):4636-8. PubMed ID: 1651809
[TBL] [Abstract][Full Text] [Related]
18. Uptake and metabolism of chlorpromazine by rat and rabbit lungs.
Ohmiya Y; Mehendale HM
Drug Metab Dispos; 1980; 8(5):313-8. PubMed ID: 6107228
[TBL] [Abstract][Full Text] [Related]
19. Bioactivation of 4-ipomeanol by CYP4B1: adduct characterization and evidence for an enedial intermediate.
Baer BR; Rettie AE; Henne KR
Chem Res Toxicol; 2005 May; 18(5):855-64. PubMed ID: 15892579
[TBL] [Abstract][Full Text] [Related]
20. Distribution and metabolism of the pulmonary alkylating agent and cytotoxin, 4-ipomeanol, in control and diethylmaleate-treated rats.
Statham CN; Boyd MR
Biochem Pharmacol; 1982 Apr; 31(8):1585-9. PubMed ID: 7092948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
